SEC Form 4 · accession 0001240122-26-000006
OnKure Therapeutics, Inc. · OKUR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael G Grey
Director
Period of report
Aug 7, 2026
Accepted (ET)
Aug 11, 2026 · 4:36 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001637715
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.14 | Aug 7, 2026 | A | 22,350 | A | — | Aug 6, 2036 | Class A Common Stock | 22,350 | 22,350 | D |
Explanation of responses
- F1100% of the shares subject to the option will vest on the earlier of June 4, 2027 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through the applicable vesting date.